Mi-Yeon Jang

Title: Innovator Spotlight: Mi-Yeon Jang

Introduction: Mi-Yeon Jang is a distinguished inventor based in Leuven, Belgium, with a notable contribution to the field of immunology. Her remarkable work has led to the development of innovative compounds that serve as vital immunosuppressive agents, significantly impacting the treatment of various disorders.

Latest Patents: Mi-Yeon Jang holds two patents centered around thiazolopyrimidine modulators. The latest patent details a compound of specific formulas, including formula I, II, III, or IV, alongside its pharmaceutical acceptable addition salts, stereoisomers, and solvates. This invention emphasizes the method of preparation and the pharmaceutical compositions derived from these compounds. Their application is particularly relevant for the treatment of immune and autoimmune disorders, as well as for mitigating organ and cell transplant rejections.

Career Highlights: Mi-Yeon Jang is affiliated with Katholieke Universiteit Leuven (KU Leuven R&D), where she contributes her expertise in pharmaceutical chemistry and immunology. Her work has not only advanced scientific understanding but has also led to practical applications in medicine.

Collaborations: Throughout her career, Mi-Yeon has collaborated with notable colleagues such as Piet Herdewijn and Steven De Jonghe. These partnerships have fostered an environment of innovation and exchange of ideas, further enhancing the impact of their research in the scientific community.

Conclusion: Mi-Yeon Jang stands as an influential figure in the realm of immunological inventions. Her patents showcase her dedication to developing solutions for complex medical challenges, reflecting her commitment to advancing human health through innovation. With continued collaboration and research, her contributions are poised to make a significant difference in medical treatments for years to come.